Heber City, UT, United States of America

Stephen Patrick Anthony

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Stephen Patrick Anthony

Introduction: Stephen Patrick Anthony, based in Heber City, Utah, stands out as a notable inventor with a significant contribution to the field of biotechnology. With one patent to his name, he focuses on groundbreaking methods for treating diseases linked to abnormal ACVR1 expression. His work is particularly relevant for those suffering from specific genetic disorders and cancers.

Latest Patents: Stephen Patrick Anthony holds a patent titled "Methods for treating diseases associated with abnormal ACVR1 expression and ACVR1 inhibitors for use in the same." This patent details innovative methods for treating various diseases by administering an ACVR1 inhibitor, including its stereoisomers, tautomers, pharmaceutically acceptable salts, and prodrugs. The subjects benefiting from this treatment may have mutations in their ACVR1 gene, allowing for potential therapies for severe diseases such as diffuse intrinsic pontine glioma (DIPG) and fibrodysplasia ossificans progressiva (FOP).

Career Highlights: During his career, Stephen has aligned with Sumitomo Dainippon Pharma Oncology, Inc., where he continues to influence the medical landscape with his innovative ideas. His focus remains on developing therapeutic solutions that are vital for patients with challenging health conditions.

Collaborations: Throughout his journey, Stephen Patrick Anthony has collaborated with esteemed colleagues such as Steven L Warner and David J Bearss. These partnerships have propelled advancements in understanding ACVR1 related diseases and have enhanced the potential for clinical applications based on his patent.

Conclusion: Stephen Patrick Anthony exemplifies the essence of innovation in the medical and biotechnology sectors. His patent for the treatment of diseases associated with ACVR1 mutations demonstrates the power of inventive thinking in addressing critical healthcare challenges. His ongoing work and collaborations continue to hold promise for future breakthroughs in the treatment of complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…